Investigation of Neutrophil Extracellular Traps as Potential Mediators in the Pathogenesis of Non-Acute Subdural Hematomas: A Pilot Study.

VEGF neutrophil extracellular trap recurrence subdural hematoma vascular endothelial growth factor

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
24 Nov 2022
Historique:
received: 20 09 2022
revised: 18 11 2022
accepted: 21 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Non-acute subdural hematomas (NASHs) are a cause of significant morbidity and mortality, particularly with recurrences. Although recurrence is believed to involve a disordered neuroinflammatory cascade involving vascular endothelial growth factor (VEGF), this pathway has yet to be completely elucidated. Neutrophil extracellular traps (NETs) are key factors that promote inflammation/apoptosis and can be induced by VEGF. We investigated whether NETs are present in NASH membranes, quantified NET concentrations, and examined whether NET and VEGF levels are correlated in NASHs. Samples from patients undergoing NASH evacuation were collected during surgery and postoperatively at 24 and 48 h. Fluid samples and NASH membranes were analyzed for levels of VEGF, NETs, and platelet activation. NASH samples contained numerous neutrophils positive for NET formation. Myeloperoxidase-DNA complexes (a marker of NETs) remained elevated 48 h postoperatively (1.06 ± 0.22 day 0, 0.72 ± 0.23 day 1, and 0.83 ± 0.33 day 2). VEGF was also elevated in NASHs (7.08 ± 0.98 ng/mL day 0, 3.40 ± 0.68 ng/mL day 1, and 6.05 ± 1.8 ng/mL day 2). VEGF levels were significantly correlated with myeloperoxidase-DNA levels. These results show that NETs are increasing in NASH, a finding that was previously unknown. The strong correlation between NET and VEGF levels indicates that VEGF may be an important mediator of NET-related inflammation in NASH.

Identifiants

pubmed: 36552941
pii: diagnostics12122934
doi: 10.3390/diagnostics12122934
pmc: PMC9776444
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : NHLBI R01HL163019
Pays : United States

Références

Circ Res. 2007 Mar 30;100(6):904-13
pubmed: 17322177
Surg Neurol. 1991 Jun;35(6):441-5
pubmed: 1905064
Biochem Biophys Res Commun. 1991 Dec 16;181(2):902-6
pubmed: 1755866
J Neurosurg. 1986 Aug;65(2):183-7
pubmed: 3723175
J Neurosurg. 2015 Nov;123(5):1209-15
pubmed: 25794342
J Med Dent Sci. 2009 Sep;56(3):101-6
pubmed: 20099472
J Clin Invest. 2012 Jul;122(7):2661-71
pubmed: 22684106
J Neurosurg. 1981 May;54(5):637-45
pubmed: 7014792
Acta Neuropathol Commun. 2019 Jun 10;7(1):94
pubmed: 31177989
Front Immunol. 2019 Jan 08;9:3076
pubmed: 30671057
Blood. 2014 Jun 12;123(24):3818-27
pubmed: 24620350
J Clin Invest. 2016 Oct 3;126(10):3783-3798
pubmed: 27599294
Blood. 2020 Sep 3;136(10):1169-1179
pubmed: 32597954
World Neurosurg. 2011 May-Jun;75(5-6):731-6; discussion 620-3
pubmed: 21704944
Cells. 2019 Nov 21;8(12):
pubmed: 31766346
Nat Commun. 2020 May 19;11(1):2488
pubmed: 32427863
Neurol Med Chir (Tokyo). 2009 Sep;49(9):379-85
pubmed: 19779281
J Clin Invest. 2022 May 16;132(10):
pubmed: 35358095
BMC Cell Biol. 2010 May 26;11:36
pubmed: 20500895
Ann Neurol. 2017 Aug;82(2):223-232
pubmed: 28696508
FASEB J. 2021 Sep;35(9):e21835
pubmed: 34449927
Semin Cancer Biol. 2013 Jun;23(3):149-58
pubmed: 23410638
J Trauma Acute Care Surg. 2021 Dec 1;91(6):e134-e141
pubmed: 34538825
Biosci Rep. 2018 Sep 7;38(5):
pubmed: 29440456
World Neurosurg. 2017 Nov;107:376-381
pubmed: 28754640
Brain Res. 2015 Nov 2;1625:84-96
pubmed: 26315377
Thromb Haemost. 2017 Oct 5;117(10):1919-1929
pubmed: 28837206
J Neurotrauma. 2016 Jan 1;33(1):65-70
pubmed: 25646653
Sci Rep. 2021 Nov 17;11(1):22463
pubmed: 34789851
Neurosurg Clin N Am. 2000 Jul;11(3):447-54
pubmed: 10918014
Nat Med. 2001 May;7(5):575-83
pubmed: 11329059
Nat Med. 2009 Jun;15(6):623-5
pubmed: 19448636
Acta Neurochir (Wien). 1998;140(1):51-5
pubmed: 9522908
Cureus. 2022 May 6;14(5):e24779
pubmed: 35673314
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Acta Neurochir (Wien). 2001 Aug;143(8):811-8; discussion 819
pubmed: 11678402
Clin Neurol Neurosurg. 2005 Apr;107(3):223-9
pubmed: 15823679
J Neurosurg. 1983 Aug;59(2):298-303
pubmed: 6864298
No Shinkei Geka. 1993 Aug;21(8):697-701
pubmed: 8361567
Front Neurol. 2020 Jun 19;11:550
pubmed: 32636797
EBioMedicine. 2020 Mar;53:102671
pubmed: 32114386

Auteurs

Michael T Bounajem (MT)

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT 84112, USA.

Frederik Denorme (F)

Program in Molecular Medicine, University of Utah, Salt Lake City, UT 84112, USA.

John L Rustad (JL)

Program in Molecular Medicine, University of Utah, Salt Lake City, UT 84112, USA.

Robert A Campbell (RA)

Program in Molecular Medicine, University of Utah, Salt Lake City, UT 84112, USA.
Department of Internal Medicine, Division of General Medicine, University of Utah, Salt Lake City, UT 84112, USA.
Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT 84112, USA.

Ramesh Grandhi (R)

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT 84112, USA.

Classifications MeSH